Reviewdiamond2022

COVID-19 Vaccine Challenges in Developing and Developed Countries

Harshani Yarlagadda · Meet A Patel · Vasu Gupta · Toram Bansal · Shubekshya Upadhyay · Nour Shaheen +1 more

58 citations0/0 files storedCureus

No readable copy stored yet — this record is metadata only.

Vaccine Coverage and Hesitancy SARS-CoV-2 and COVID-19 Research Legal, Health, Environmental and COVID-19 Challenges

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has led to significant psychological and economical distress. Within a year after COVID-19 was declared a pandemic, several vaccines against COVID-19 were approved for emergency use. The journey from vaccine discovery to global herd immunity against COVID-19 continues to present significant challenges revolving around its development, affordability, accessibility, and acceptability at both a country level and an individual level. The main challenge faced by developed countries is the acceptability of the COVID-19 vaccine and the main challenge faced by developing countries is the affordability and accessibility of the COVID-19 vaccine.

Citations in this library

Stored only when both papers are in the corpus — 58 citations exist upstream.

References

2020A global survey of potential acceptance of a COVID-19 vaccine 2021Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment 2020Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China 2021COVID-19 Vaccine Acceptance among Health Care Workers in the United States 2021Understanding COVID-19 vaccine hesitancy 2021Access to and equitable distribution of COVID-19 vaccine in low-income countries 2021Addressing challenges to rolling out COVID-19 vaccines in African countries 2020Sample study protocol for adapting and translating the 5C scale to assess the psychological antecedents of vaccination

Imported from OpenAlex (CC0) — nothing here is generated.